# François Goldwasser

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francois-goldwasser/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,552 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 61 |
| i10-index | 193 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5065121477 |
| ORCID iD | https://orcid.org/0000-0002-7128-6128 |
| Works | 566 |

## Researcher papers

- [Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors](https://scholariq.org/papers/gut-microbiome-influences-efficacy-of-pd-1-based-immunotherapy-against/)
- [Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer](https://scholariq.org/papers/intestinal-akkermansia-muciniphila-predicts-clinical-response-to-pd-1-blockade/)
- [<i>TP53, STK11</i> , and <i>EGFR</i> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma](https://scholariq.org/papers/i-tp53-stk11-i-and-i-egfr-i-mutations-predict-tumor-immune-profile-and-the/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.